1887
  1. Home
  2. Eurosurveillance
  3. Volume 23, Issue 40, 04/Oct/2018
  4. Article
Research article Open Access
Like 0
Download

Abstract

Introduction

Neurocysticercosis (NCC) is one of the leading causes of epilepsy worldwide. The majority of cases in Europe are diagnosed in immigrants. Currently in Italy, routine serological screening for cysticercosis is recommended for internationally adopted children (IAC) coming from endemic countries. We retrospectively analyse the results of the serological screening for cysticercosis in IAC 16 years old or younger, attending two Italian third level paediatric clinics in 2001–16. Of 2,973 children included in the study, 2,437 (82.0%) were screened by enzyme-linked immune electro transfer blot (EITB), 1,534 (51.6%) by ELISA, and 998 (33.6%) by both tests. The seroprevalence of cysticercosis ranged between 1.7% and 8.9% according to EITB and ELISA, respectively. Overall, 13 children were diagnosed with NCC accounting for a NCC frequency of 0.4% (95% confidence interval (CI): 0.2–0.6%). Among the 168 seropositive children, only seven (4.2%) were diagnosed with NCC. Of these children, three were asymptomatic and four presented epilepsy. Among seronegative children (n = 2,805), seven presented with neurological symptoms that lead to the diagnosis of NCC in six cases. The sensitivity, specificity, positive and negative predictive value for the diagnosis of NCC were 54.5%, 98.6%, 14.6%, 99.8% for EITB and 22.2%, 91.1%, 1.4%, 99.5% for ELISA. The yield of the screening programme was 437 NCC cases per 100,000. The number needed to screen to detect one NCC case was 228. The cost per NCC case detected was EUR 10,372. On the base of our findings we suggest the ongoing serological screening for cysticercosis to be discontinued, at least in Italy, until further evidence in support will be available.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.40.1700709
2018-10-04
2024-12-22
/content/10.2807/1560-7917.ES.2018.23.40.1700709
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/23/40/eurosurv-23-40-3.html?itemId=/content/10.2807/1560-7917.ES.2018.23.40.1700709&mimeType=html&fmt=ahah

References

  1. Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13(12):1202-15.  https://doi.org/10.1016/S1474-4422(14)70094-8  PMID: 25453460 
  2. Cantey PT, Coyle CM, Sorvillo FJ, Wilkins PP, Starr MC, Nash TE. Neglected parasitic infections in the United States: cysticercosis. Am J Trop Med Hyg. 2014;90(5):805-9.  https://doi.org/10.4269/ajtmh.13-0724  PMID: 24808248 
  3. Zammarchi L, Strohmeyer M, Bartalesi F, Bruno E, Muñoz J, Buonfrate D, et al. Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. PLoS One. 2013;8(7):e69537.  https://doi.org/10.1371/journal.pone.0069537  PMID: 23922733 
  4. World Health Oranization (WHO). Fourth WHO report on Neglected Tropical Diseases. Integrating Neglected Tropical Diseases into Global Health and Development. Geneva: WHO; 2017.
  5. Laranjo-González M, Devleesschauwer B, Trevisan C, Allepuz A, Sotiraki S, Abraham A, et al. Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe. Parasit Vectors. 2017;10(1):349.  https://doi.org/10.1186/s13071-017-2280-8  PMID: 28732550 
  6. Willingham AL, Engels D. Control of Taenia solium cysticercosis/taeniosis. Adv Parasitol. 2006;61:509-66.  https://doi.org/10.1016/S0065-308X(05)61012-3  PMID: 16735172 
  7. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian YJ, Rainwater E, et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis. 2010;4(11):e870.  https://doi.org/10.1371/journal.pntd.0000870  PMID: 21072231 
  8. Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, et al. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(10):e2480.  https://doi.org/10.1371/journal.pntd.0002480  PMID: 24205415 
  9. Del Brutto OH. Neurocysticercosis in infants and toddlers: report of seven cases and review of published patients. Pediatr Neurol. 2013;48(6):432-5.  https://doi.org/10.1016/j.pediatrneurol.2013.02.001  PMID: 23668866 
  10. Fleury A, Morales J, Bobes RJ, Dumas M, Yánez O, Piña J, et al. An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg. 2006;100(6):551-8.  https://doi.org/10.1016/j.trstmh.2005.08.008  PMID: 16316671 
  11. Prasad KN, Verma A, Srivastava S, Gupta RK, Pandey CM, Paliwal VK. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India. Trans R Soc Trop Med Hyg. 2011;105(9):531-6.  https://doi.org/10.1016/j.trstmh.2011.06.001  PMID: 21764415 
  12. Kumar A, Mandal A, Sinha S, Singh A, Das RR. Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis. Int J Pediatr. 2017;2017:8983958.  https://doi.org/10.1155/2017/8983958  PMID: 28167968 
  13. Banerjee TK, Hazra A, Biswas A, Ray J, Roy T, Raut DK, et al. Neurological disorders in children and adolescents. Indian J Pediatr. 2009;76(2):139-46.  https://doi.org/10.1007/s12098-008-0226-z  PMID: 19082533 
  14. Gaffo AL, Guillén-Pinto D, Campos-Olazábal P, Burneo JG. Cysticercosis as the main cause of partial seizures in children in Peru. Rev Neurol. 2004;39(10):924-6. PMID: 15573306 
  15. Townes JM, Hoffmann CJ, Kohn MA. Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis. 2004;10(3):508-10.  https://doi.org/10.3201/eid1003.030542  PMID: 15109424 
  16. Zammarchi L, Angheben A, Gobbi F, Zavarise G, Requena-Mendez A, Marchese V, et al. Profile of adult and pediatric neurocysticercosis cases observed in five Southern European centers. Neurol Sci. 2016;37(8):1349-55.  https://doi.org/10.1007/s10072-016-2606-x  PMID: 27193586 
  17. Commissione per le Adozioni Internazionali (CAI) [International Adoption Committee]. L'Italia in controtendenza rispetto al calo delle adozioni internazionali di tutti gli altri Paesi di accoglienza. [Italy in contrast with the decline in international adoptions of all other host countries]. Rome: CAI; 2016. Italian. Available from: http:// http://www.commissioneadozioni.it/it/notizie/2016/dati-adozioni.aspx
  18. Hénaff F, Hazart I, Picherot G, Baqué F, Gras-Le Guen C, Launay E. Frequency and characteristics of infectious diseases in internationally adopted children: a retrospective study in Nantes from 2010 to 2012. J Travel Med. 2015;22(3):179-85.  https://doi.org/10.1111/jtm.12196  PMID: 25787709 
  19. Eckerle JK, Howard CR, John CC. Infections in internationally adopted children. Pediatr Clin North Am. 2013;60(2):487-505.  https://doi.org/10.1016/j.pcl.2012.12.010  PMID: 23481113 
  20. Sollai S, Ghetti F, Bianchi L, de Martino M, Galli L, Chiappini E. Infectious diseases prevalence, vaccination coverage, and diagnostic challenges in a population of internationally adopted children referred to a Tertiary Care Children’s Hospital from 2009 to 2015. Medicine (Baltimore). 2017;96(12):e6300.  https://doi.org/10.1097/MD.0000000000006300  PMID: 28328809 
  21. Chiappini E, Sollai S, de Martino M, Galli L. Malaria in Children Adopted from the Democratic Republic of the Congo. Emerg Infect Dis. 2017;23(4):721-2.  https://doi.org/10.3201/eid2304.161777  PMID: 28322706 
  22. Valentini P, Gargiullo L, Ceccarelli M, Ranno O. Health status of internationally adopted children. The experience of an Italian "GLNBI" paediatric centre. Ital J Public Health. 2012;9:e7527-32.
  23. Gruppo di Lavoro Nazionale per il Bambino Migrante della Società Italiana di Pediatria. [National Working Group for the Migrant Child of the Italian Society of Paediatrics]. Italy: Società Italiana di Pediatria [Italian Society of Paediatrics]. Italian. Available from: http://www.glnbi.org/
  24. Adami Lami C, Gabrielli C, Zaffaroni M, Cataldo F, Valentini F, et al. (2007) Nuovo Protocollo 2007 per l'accoglienza sanitaria del bambino adottato all'estero. [New Protocol 2007 for health-reception of internationally adopted children]. Atti Congresso della Società Italiana di Pediatria, 2007.[Proceedings of the Congress of the Italian Society of Paediatrics]. Italian. Available from: http://www.glnbi.org/documenti/ad88407a4ca3bff42fa5666d67028df0.pdf
  25. Zavarise G. Protocollo del "Gruppo di Lavoro Nazionale per il Bambino Migrante" (GLNBI) per il bambino adottato 2013 Bozza proposta per revisione del protocollo per l'accoglienza sanitaria del bambino adottato all'estero. [Protocol of the "National Working Group for the Migrant Child" for the adopted children. Draft proposal for the revision of the protocol for health-reception for internationally adopted children 2013]. Riunione del Gruppo di Lavoro Nazionale per il Bambino Migrante della Società Italiana di Pediatria [Meeting of the National Working Group for the Migrant Child of the Italian Society of Paediatrics], Bologna 9 maggio 2013. Italian. Available from: http://www.glnbi.org/documenti/869858a7d1b145d4f04e3c368e15f8df.pdf
  26. Protocollo diagnostico-assistenziale per i bambini adottati all’estero. [Protocol for diagnosis and management of internationally adopted children]. In: Atti del 58° Congresso della Società Italiana di Pediatria. [Proceedings of the 58th Congress of the Italian Society of Paediatrics]; 2002 30 Sep-2 Oct.; Montecatini, Italy. Italian
  27. Blanchi S, Chabasse D, Pichard E, Darviot E, de Gentile L. Post-international adoption medical follow-up at the Angers university hospital between 2009 and 2012. Med Mal Infect. 2014;44(2):69-75.  https://doi.org/10.1016/j.medmal.2013.12.003  PMID: 24486252 
  28. Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, Wilkins PP, Singh G, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202-10.  https://doi.org/10.1016/j.jns.2016.11.045  PMID: 28017213 
  29. LDBIO Diagnostics (2016) Cysticercosis Western Blot IgG. Instruction for use.
  30. DRG International Inc USA (2011) Enzyme Linked Immune Assay, Taenia Solium IgG. Package insert.
  31. QualicodeTM Cysticercosis kit (Immunetics Inc., Boston, Massachusetts, USA. Package Insert. [Accessed 21 Aug 2017]. Available from: https://wwwyumpucom/en/document/view/26499278/qualicodea-cysticercosis-kit-invitech
  32. Catalogo Aziendale (ex nomenclatore) 2006. [Organisation’s catalogue 2006]. Florence Italy: Azienda Ospedaliero Universitaria Careggi; 2016.
  33. Catalogo Regionale Prescivibile. [Prescivable Regional Catalogue]. Regione del Veneto; 2016.
  34. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, Mukaratirwa S, et al. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop. 2003;87(1):13-23.  https://doi.org/10.1016/S0001-706X(03)00051-2  PMID: 12781374 
  35. Dixon H, Lipscomb F. Cysticercosis: An analysis and follow up of 450 cases. Medical Research Council Special Report Series, London. 1961;299:1-58.
  36. Garcia HH, Rodriguez S, Gilman RH, Gonzalez AE, Tsang VC, Cysticercosis Working Group in Peru. Neurocysticercosis: is serology useful in the absence of brain imaging? Trop Med Int Health. 2012;17(8):1014-8.  https://doi.org/10.1111/j.1365-3156.2012.03037.x  PMID: 22809375 
  37. Moyano LM, O’Neal SE, Ayvar V, Gonzalvez G, Gamboa R, Vilchez P, et al. High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in Peru. PLoS Negl Trop Dis. 2016;10(12):e0005130.  https://doi.org/10.1371/journal.pntd.0005130  PMID: 27992429 
  38. Garcia HH, Del Brutto OH, Cysticercosis Working Group in Peru. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution. Epilepsy Behav. 2017;76:158-62.  https://doi.org/10.1016/j.yebeh.2017.03.013  PMID: 28606690 
  39. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J. 1998;17(8):696-700.  https://doi.org/10.1097/00006454-199808000-00007  PMID: 9726343 
  40. Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2008;79(9):1050-5.  https://doi.org/10.1136/jnnp.2008.144899  PMID: 18495737 
  41. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004;350(3):249-58.  https://doi.org/10.1056/NEJMoa031294  PMID: 14724304 
  42. Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. 2003;97(4):416-21.  https://doi.org/10.1016/S0035-9203(03)90075-7  PMID: 15259471 
  43. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr. 2003;143(1):111-4.  https://doi.org/10.1016/S0022-3476(03)00211-7  PMID: 12915835 
  44. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol. 2004;19(5):323-7.  https://doi.org/10.1177/088307380401900503  PMID: 15224704 
  45. Zammarchi L, Bonati M, Strohmeyer M, Albonico M, Requena-Méndez A, Bisoffi Z, et al. Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. Trop Med Int Health. 2017;22(7):881-94.  https://doi.org/10.1111/tmi.12887  PMID: 28449318 
  46. Centers for Disease Control and Prevention (CDC). Intestinal parasite guidelines for domestic medical examination for newly arrived refugees. Atlanta: CDC; 2013. Available from: https://www.cdc.gov/immigrantrefugeehealth/pdf/intestinal-parasites-domestic.pdf
  47. Rajshekhar V, Oommen A. Serological studies using ELISA and EITB in patients with solitary cysticercus granuloma and seizures. Neurol Infect Epidemiol.1997;2:177-80.
  48. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol. 2000;15(4):207-13.  https://doi.org/10.1177/088307380001500401  PMID: 10805184 
  49. Staat MA, Rice M, Donauer S, Mukkada S, Holloway M, Cassedy A, et al. Intestinal parasite screening in internationally adopted children: importance of multiple stool specimens. Pediatrics. 2011;128(3):e613-22. PMID: 21824880 
  50. Sarfaty M, Rosenberg Z, Siegel J, Levin RM. Intestinal parasites in immigrant children from Central America. West J Med. 1983;139(3):329-31. PMID: 6636747 
  51. Zammarchi L, Casadei G, Strohmeyer M, Bartalesi F, Liendo C, Matteelli A, et al. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries. BMC Health Serv Res. 2015;15(1):412.  https://doi.org/10.1186/s12913-015-1045-3  PMID: 26399233 
  52. Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax. 2010;65(2):178-80.  https://doi.org/10.1136/thx.2009.119677  PMID: 19996345 
  53. Garcia HH, Castillo Y, Gonzales I, Bustos JA, Saavedra H, Jacob L, et al. Low sensitivity and frequent cross-reactions in commercially available antibody detection ELISA assays for Taenia solium cysticercosis. Trop Med Int Health. 2018;23(1):101-5.  https://doi.org/10.1111/tmi.13010  PMID: 29160912 
  54. Carod JF, Randrianarison M, Razafimahefa J, Ramahefarisoa RM, Rakotondrazaka M, Debruyne M, et al. Evaluation of the performance of 5 commercialized enzyme immunoassays for the detection of Taenia solium antibodies and for the diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis. 2012;72(1):85-9.  https://doi.org/10.1016/j.diagmicrobio.2011.09.014  PMID: 22085773 
  55. Carvalho Junior RM, Costa DL, Soares SC, Costa CH. Evaluation of an enzyme immunoassay for clinical diagnosis of neurocysticercosis in symptomatic patients. Rev Soc Bras Med Trop. 2010;43(6):647-50.  https://doi.org/10.1590/S0037-86822010000600009  PMID: 21181016 
  56. Chuang C, Xing-Wang C, Jian-Zhong D, Tiao-Ying L. [Evaluation of ELISA kit for detection of serum specific IgG antibodies against Taenia solium in diagnosis of human cysticercosis]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2017;29(2):228-30. PMID: 29469334 
  57. Das A, Goyal R, Saxena S, Singh NP. Diagnosis of neurocysticercosis by enzyme-linked immunosorbent assay. J Indian Med Assoc. 2005;103(10):528-9. PMID: 16498754 
Screening for neurocysticercosis in internationally adopted children: yield, cost and performance of serological tests, Italy, 2001 to 2016
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Lorenzo+Zammarchi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zammarchi Lorenzo</a>, <a href="/search?value1=Andrea+Angheben&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Angheben Andrea</a>, <a href="/search?value1=Teresa+Fantoni&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fantoni Teresa</a>, <a href="/search?value1=Elena+Chiappini&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Chiappini Elena</a>, <a href="/search?value1=Antonia+Mantella&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mantella Antonia</a>, <a href="/search?value1=Luisa+Galli&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Galli Luisa</a>, <a href="/search?value1=Valentina+Marchese&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Marchese Valentina</a>, <a href="/search?value1=Giorgio+Zavarise&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zavarise Giorgio</a>, <a href="/search?value1=Zeno+Bisoffi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bisoffi Zeno</a>, <a href="/search?value1=Alessandro+Bartoloni&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bartoloni Alessandro</a></span>. Screening for neurocysticercosis in internationally adopted children: yield, cost and performance of serological tests, Italy, 2001 to 2016. <a href="/content/ecdc">Euro Surveill.</a> 2018;23(40):pii=1700709. <a href="https://doi.org/10.2807/1560-7917.ES.2018.23.40.1700709" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2018.23.40.1700709</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 21 Oct 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Apr 2018 </span> </p>
/content/10.2807/1560-7917.ES.2018.23.40.1700709
/content/10.2807/1560-7917.ES.2018.23.40.1700709
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error